Skip to main content
TipRanks
Go Ultimate75% OFF

Marc Blaustein Insider Profile

4 Followers

Marc Blaustein, former COO at Finch Therapeutics Group, holds 28.00K shares in Finch Therapeutics Group (Ticker: FNCHQ). Most recently, Marc Blaustein Sold 4,619 shares of Finch Therapeutics Group on Feb 23, 2023 for an estimated value of $1.76K.

Marc Blaustein's Trading History

FNCHQ
Finch Therapeutics Group
Feb 23, 2023―Informative Sell1.76K$289.75K
FNCHQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 23, 2023Informative Sell$1.76K4,619$0.38+77.70%
Oct 25, 2022Informative Sell$5.05K3,636$1.39+91.30%
Jun 15, 2022Uninformative Buy$0.0035,000$0.00―

You May Also Like

Marc Blaustein insider profile FAQ

What is the percentage of profitable transactions made by Marc Blaustein?
The percentage of profitable transactions made by Marc Blaustein is 100%.
What is the average return per transaction made by Marc Blaustein?
The average return per transaction made by Marc Blaustein is 84.50%.
What stocks does Marc Blaustein hold?
Marc Blaustein holds: FNCHQ stocks.
What was Marc Blaustein’s latest transaction?
Marc Blaustein’s latest transaction was an Informative Sell of $1.76K.
What was Marc Blaustein's most profitable transaction?
Marc Blaustein’s most profitable transaction was an Informative Sell of FNCHQ stock on October 25, 2022. The return on the trade was 91.30%.
What is Marc Blaustein's role in Finch Therapeutics Group?
Marc Blaustein's role in Finch Therapeutics Group is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.